Skip to content

Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease

The Effects of Orbital Decompression Surgery on Intraocular Pressure Patterns in Patient With Thyroid Eye Disease Undergoing 24 Hour Continuous IOP Monitoring With the SENSIMED Triggerfish®

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01798966
Enrollment
10
Registered
2013-02-26
Start date
2013-02-28
Completion date
2013-06-30
Last updated
2016-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Eye Disease

Brief summary

Patients with Thyroid Eye Disease (TED) often have enlarged extraocular muscles and higher orbital fat contents due to their disease process. The confined space of the orbit cannot hold the enlarged orbital contents creating a forward displacement and/or compression of the globe with a rise in intraocular pressure (IOP). Many of these patients undergo surgical decompression, a procedure that fractures orbital bones, in order to allow more space for the enlarged orbital contents to occupy. To date, there is no data that shows intraocular patterns over a 24-hour period in patients with mechanical compression on the globe as in TED. It is not know if the pattern of IOP is more consistent with normal IOP patterns, glaucomatous patterns, or perhaps completely different then either. The goal of this project is to investigate patterns of IOP in patients requiring orbital decompression because of orbital congestion. Changes in IOP during a 24-hour period will be studied with a contact-lens embedded sensor that provides continuous data. This device has previously been investigated and shown to be safe and well-tolerated. Monitoring the pattern in these patients will allow us to compare Thyroid TED patterns of IOP with those of normal and glaucomatous patients. Also, testing these patients before and after orbital decompression surgery will allow characterization of how intraocular pressure changes once the mechanical compression on the globe is relieved.

Interventions

Sponsors

University of California, San Diego
CollaboratorOTHER
Sensimed AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Subject is able to comply with the study procedures * 18-80 years old * Subjects diagnosed with Thyroid Eye Disease based on both endocrinology studies showing autoimmune dysfunction consistent with Graves' Disease as well as orbital imaging studies manifesting characteristics consistent with Thyroid Eye Disease. * Ability to understand the character and individual consequences of the study * Subject has consented to be in the trial

Exclusion criteria

* Subjects with contraindications for wearing contact lenses * Severe ocular surface disease * Keratoconus or other corneal abnormality * Severe ocular inflammation * Full frame metal glasses during SENSIMED Triggerfish® monitoring * Known hypersensitivity to silicone, plaster or ocular anesthesia (proparacaine) * Simultaneous participation in other clinical studies * Diagnosis of glaucoma

Design outcomes

Primary

MeasureTime frameDescription
Change in IOP Before and After Orbital Decompression Surgery24 hoursTo investigate the difference in SENSIMED Triggerfish output during transition from wake to sleep states before and after orbital decompression

Secondary

MeasureTime frameDescription
IOP Patterns24 hoursThe pattern of IOP in patients with TED will be compared with the pattern of IOP readings in normal subjects as well as glaucomatous patients

Other

MeasureTime frameDescription
Adverse Events and Serious Adverse Events4 daysSafety will be evaluated throughout the duration of the study by collecting all adverse events

Countries

United States

Participant flow

Participants by arm

ArmCount
SENSIMED Triggerfish
All patients included in the device group
10
Total10

Baseline characteristics

CharacteristicSENSIMED Triggerfish
Age, Continuous61.8 years
STANDARD_DEVIATION 21.6
Region of Enrollment
United States
10 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
1 Participants
Tolerability of CLS1.5 units on a scale
STANDARD_DEVIATION 0.7

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
10 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Change in IOP Before and After Orbital Decompression Surgery

To investigate the difference in SENSIMED Triggerfish output during transition from wake to sleep states before and after orbital decompression

Time frame: 24 hours

ArmMeasureValue (MEDIAN)Dispersion
SENSIMED TriggerfishChange in IOP Before and After Orbital Decompression Surgery18 mVEq (Sensismed Triggerfish output unit)Standard Deviation 43.8
Secondary

IOP Patterns

The pattern of IOP in patients with TED will be compared with the pattern of IOP readings in normal subjects as well as glaucomatous patients

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
SENSIMED TriggerfishIOP Patterns102.2 mvEqStandard Deviation 52.6
Other Pre-specified

Adverse Events and Serious Adverse Events

Safety will be evaluated throughout the duration of the study by collecting all adverse events

Time frame: 4 days

ArmMeasureValue (NUMBER)
SENSIMED TriggerfishAdverse Events and Serious Adverse Events3 Number of AE

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026